Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (168)

81

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin

enthalten in: Deutsche medizinische Wochenschrift (1946) | 2013

von Nauck, M. | del Prato, S. | Meier, J. | +4

82

Analyse der Therapiedurchführung bei den in Deutschland behandelten Patienten der internationalen, multizentrischen und randomisierten Phase-III-Studie Relapsed AML 2001/01

Erschienen: 2013

von Semmler, J. | Reinhardt, D.

83

Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin in rectal cancer : initial results of the CAO/ARO/AIO-04 study

enthalten in: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen | 2012

von Reibetanz, J. | Germer, C.

84

Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy : a multicenter, randomized, open, controlled, parallel group phase III study

enthalten in: Der Nervenarzt | 2012

von Steinhoff, B. | Stefan, H. | Schulze-Bonhage, A. | +4

85

First-line therapy of advanced or metastasized renal cell cancer : open randomized phase III sequence study to examine the effectiveness and tolerance of sorafenib followed by pazopanib versus pazopanib followed by sorafenib in the first-line treatment of patients with advanced or metastasized renal cell cancer (SWITCH-2 - AN 33/11)

enthalten in: Der Urologe. Ausg. A | 2012

von Rexer, H.

86

Third-line therapy for metastasized renal cell carcinoma : a randomized, multicenter non-blinded phase III study to compare safety and effectiveness of TF1258 versus sorafenib in patients with metastasized renal cell carcinoma following failure of antiangiogenic (VEGF targeted and mTOR inhibition) therapy (GOLD-AN 31/11 of the Working Group Urological Oncology)

enthalten in: Der Urologe. Ausg. A | 2011

von Rexer, H.

87

AUO study AP 59/10 : first-line therapy of castration-resistant prostate cancer

enthalten in: Der Urologe. Ausg. A | 2011

von Rexer, H.

88

AH-10/04 - international study on testicular cancer : randomized phase III study 1xBEP in comparison to 2xBEP for patients with non-seminomatous testicular cancer in clinical stage I (high risk)

enthalten in: Der Urologe. Ausg. A | 2011

von Rexer, H.

89

Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I

enthalten in: Der Urologe. Ausg. A | 2009

von Hartmann, M. | Siener, R. | Krege, S. | +14

90

BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study

enthalten in: Aktuelle Urologie | 2009

von Jocham, D. | von Wietersheim, J. | Pflüger, H. | +5